CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

AIM2-driven inflammasome activation in heart failure Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Leaflet immobility and thrombosis in transcatheter aortic valve replacement Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF